Anti-CLEC4F monoclonal antibody

Pre-made anti-CLEC4F monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CLEC4F/CLEC4F products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0559-Ab-1/ GM-Tg-hg-IP0559-Ab-2Anti-Human CLEC4F monoclonal antibodyHuman
GM-Tg-rg-IP0559-Ab-1/ GM-Tg-rg-IP0559-Ab-2Anti-Rat CLEC4F monoclonal antibodyRat
GM-Tg-mg-IP0559-Ab-1/ GM-Tg-mg-IP0559-Ab-2Anti-Mouse CLEC4F monoclonal antibodyMouse
GM-Tg-cynog-IP0559-Ab-1/ GM-Tg-cynog-IP0559-Ab-2Anti-Cynomolgus/ Rhesus macaque CLEC4F monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0559-Ab-1/ GM-Tg-felg-IP0559-Ab-2Anti-Feline CLEC4F monoclonal antibodyFeline
GM-Tg-cang-IP0559-Ab-1/ GM-Tg-cang-IP0559-Ab-2Anti-Canine CLEC4F monoclonal antibodyCanine
GM-Tg-bovg-IP0559-Ab-1/ GM-Tg-bovg-IP0559-Ab-2Anti-Bovine CLEC4F monoclonal antibodyBovine
GM-Tg-equg-IP0559-Ab-1/ GM-Tg-equg-IP0559-Ab-2Anti-Equine CLEC4F monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0559-Ab-1/ GM-Tg-hg-IP0559-Ab-2; GM-Tg-rg-IP0559-Ab-1/ GM-Tg-rg-IP0559-Ab-2;
GM-Tg-mg-IP0559-Ab-1/ GM-Tg-mg-IP0559-Ab-2; GM-Tg-cynog-IP0559-Ab-1/ GM-Tg-cynog-IP0559-Ab-2;
GM-Tg-felg-IP0559-Ab-1/ GM-Tg-felg-IP0559-Ab-2; GM-Tg-cang-IP0559-Ab-1/ GM-Tg-cang-IP0559-Ab-2;
GM-Tg-bovg-IP0559-Ab-1/ GM-Tg-bovg-IP0559-Ab-2; GM-Tg-equg-IP0559-Ab-1/ GM-Tg-equg-IP0559-Ab-2
Products NameAnti-CLEC4F monoclonal antibody
Formatmab
Target NameCLEC4F
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CLEC4F monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0559-Ag-1Recombinant multi-species CLC4F/ CLEC4F/ CLECSF13 protein


    Target information

    Target IDGM-IP0559
    Target NameCLEC4F
    Gene ID165530,51811,114598,703303,481424,101095892,511001,100060281
    Gene Symbol and SynonymsCLEC4F,CLECSF13,KCLR,KCR,KUCR_MOUSE
    Uniprot AccessionQ8N1N0,P10716
    Uniprot Entry NameCLC4F_HUMAN,CLC4F_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000152672
    Target ClassificationN/A

    The target: CLEC4F, gene name: CLEC4F, also named as CLECSF13, KCLR. Predicted to enable galactose binding activity and glycolipid binding activity. Predicted to be involved in endocytosis. Predicted to act upstream of or within NK T cell activation. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.